Chlorogenic acid restrains tumor progression by inhibiting myeloid-derived suppressor cell ferroptosis and restoring CD8⁺ T cell function

Chlorogenic acid (CGA), a naturally occurring polyphenol abundant in coffee and tea, has demonstrated antitumor activity in multiple experimental models. However, the cellular targets and mechanisms of CGA remain incompletely understood. Myeloid-derived suppressor cells (MDSCs) are key immunosuppressive components of the tumor microenvironment. Here, we investigated whether CGA regulates MDSC ferroptosis, thereby influencing tumor progression and antitumor immunity. We established MDSC-conditioned medium systems using tumor cells or CD8⁺ T cells as responder cells and evaluated the effects of CGA in murine models of lung cancer and hepatocellular carcinoma. Our results showed that CGA protected MDSCs from ferroptosis and reduced ferroptosis-associated lipid peroxidation. Consequently, conditioned medium derived from CGA-treated MDSCs showed a reduced capacity to promote tumor cell proliferation and migration and was less effective at suppressing CD8⁺ T cell function. In vivo, CGA significantly suppressed tumor growth in murine models of lung cancer and hepatocellular carcinoma and reduced the expression of MDSC-associated immunosuppressive factors within tumors. Flow cytometric analysis further revealed a lower proportion of BODIPY-positive cells among tumor-infiltrating CD11b⁺GR-1⁺ MDSCs in CGA-treated mice. CGA treatment also enhanced intratumoral CD8⁺ T cell responses. Mechanistically, CGA promoted NRF2 nuclear accumulation and increased GPX4 expression in MDSCs. NRF2 knockdown abolished the protective effect of CGA against MDSC ferroptosis. Together, these findings indicate that CGA restrains tumor progression, at least in part, by modulating MDSC ferroptosis through an NRF2-dependent mechanism. Collectively, these data identify MDSCs as a potential cellular target of CGA and support further evaluation of CGA as an immunomodulatory anticancer agent.

Authors

Institutions

Publication Details

Journal
Translational Oncology
Published
2026-11-16
DOI
https://doi.org/10.1016/j.tranon.2026.103111
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chlorogenic acid restrains tumor progression by inhibiting myeloid-derived suppressor cell ferroptosis and restoring CD8⁺ T cell function

Liping You, Yan Li, Yuli Wang, Hongjie Yu et al.
2 links
Translational Oncology
Immune cells in cancer
article

Chlorogenic acid restrains tumor progression by inhibiting myeloid-derived suppressor cell ferroptosis and restoring CD8⁺ T cell function

Liping You, Yan Li, Yuli Wang, Hongjie Yu, Ziyi Zhou, Jiacheng Lin, Wenli Yuan
article en

Abstract

Chlorogenic acid (CGA), a naturally occurring polyphenol abundant in coffee and tea, has demonstrated antitumor activity in multiple experimental models. However, the cellular targets and mechanisms of CGA remain incompletely understood. Myeloid-derived suppressor cells (MDSCs) are key immunosuppressive components of the tumor microenvironment. Here, we investigated whether CGA regulates MDSC ferroptosis, thereby influencing tumor progression and antitumor immunity. We established MDSC-conditioned medium systems using tumor cells or CD8⁺ T cells as responder cells and evaluated the effects of CGA in murine models of lung cancer and hepatocellular carcinoma. Our results showed that CGA protected MDSCs from ferroptosis and reduced ferroptosis-associated lipid peroxidation. Consequently, conditioned medium derived from CGA-treated MDSCs showed a reduced capacity to promote tumor cell proliferation and migration and was less effective at suppressing CD8⁺ T cell function. In vivo, CGA significantly suppressed tumor growth in murine models of lung cancer and hepatocellular carcinoma and reduced the expression of MDSC-associated immunosuppressive factors within tumors. Flow cytometric analysis further revealed a lower proportion of BODIPY-positive cells among tumor-infiltrating CD11b⁺GR-1⁺ MDSCs in CGA-treated mice. CGA treatment also enhanced intratumoral CD8⁺ T cell responses. Mechanistically, CGA promoted NRF2 nuclear accumulation and increased GPX4 expression in MDSCs. NRF2 knockdown abolished the protective effect of CGA against MDSC ferroptosis. Together, these findings indicate that CGA restrains tumor progression, at least in part, by modulating MDSC ferroptosis through an NRF2-dependent mechanism. Collectively, these data identify MDSCs as a potential cellular target of CGA and support further evaluation of CGA as an immunomodulatory anticancer agent.

Translational OncologyVol. 75
Chinese University of Hong Kong (HK), Shanghai University of Traditional Chinese Medicine (CN), Shanghai Traditional Chinese Medicine Hospital (CN), Shuguang Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon